At a glance
- Originator Gedeon Richter
- Class Antipsychotics; Piperazines
- Mechanism of Action Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 21 Sep 2006 Discontinued - Preclinical for Psychotic disorders in Hungary (unspecified route)
- 25 Jun 2001 No-Development-Reported for Psychotic disorders in Hungary (Unknown route)
- 04 Sep 1998 Preclinical development for Psychotic disorders in Hungary (Unknown route)